Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Morphine sustained-release for refractory dyspnea in advanced COPD
NL-OMON47485Active, not recruiting
- Sponsor
- Maastricht University Medical Center+
- Start
- Nov 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial in Dyspnoea (SOB) and chronic obstructive pulmonary disease (COPD) comparing Morphine SR with Placebo (2 arms). Primary endpoints: Health-related quality of life and Respiratory parameters. Started Nov 2016; status: active, not recruiting.
02
Drugs
morphine
03
Conditions
Dyspnoea (SOB)chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NL-OMON47485.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON47485.